Endometrial Cancer After Endometrial Ablation vs Medical Management of Abnormal Uterine Bleeding

Journal of Minimally Invasive Gynecology

Volumn 21, Issue 5, 2014, Pages 744-752

  Dood, Robert L ^a,b   Gracia, Clarisa R ^a,b   Sammel, Mary D ^a,b   Haynes, Kevin ^a   Senapati, Suneeta ^a,b   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Endometrial ablation techniques; Endometrial neoplasms; Menorrhagia; Uterine neoplasms

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; DELAYED DIAGNOSIS; ENDOMETRIUM ABLATION; ENDOMETRIUM CANCER; FEMALE; HAZARD RATIO; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MEDICAL CARE; MENORRHAGIA; QUESTIONNAIRE; RETROSPECTIVE STUDY; UTERUS BLEEDING; ADVERSE EFFECTS; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; ENDOMETRIAL NEOPLASMS; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; RISK; UNITED KINGDOM; UTERINE NEOPLASMS;

ADULT; AGED; COHORT STUDIES; DELAYED DIAGNOSIS; ENDOMETRIAL ABLATION TECHNIQUES; ENDOMETRIAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MENORRHAGIA; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS;

EID: 84908218413     PISSN: 15534650     EISSN: 15534669     Source Type: Journal    
DOI: 10.1016/j.jmig.2014.02.012     Document Type: Article

References (49)

1. Munro M.G., Critchley H.O., Broder M.S., Fraser I.S. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet 2011, 113:3-13. FIGO Working Group on Menstrual Disorders.
2. Marjoribanks J., Lethaby A., Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2006, (19):CD003855.
3. Barrington J.W., Arunkalaivanan A.S., Abdel-Fattah M. Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol 2003, 108:72-74.
4. Cooper K.G., Jack S.A., Parkin D.E., Grant A.M. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG 2001, 108:1222-1228.
5. Crosignani P.G., Vercellini P., Mosconi P., Oldani S., Cortesi I., De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997, 90:257-263.
6. de Souza S.S., Camargos A.F., de Rezende C.P., Pereira F.A., Araújo C.A., Silva Filho A.L. A randomized prospective trial comparing the levonorgestrel-releasing intrauterine system with thermal balloon ablation for the treatment of heavy menstrual bleeding. Contraception 2010, 81:226-231.
7. Rauramo I., Elo I., Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstet Gynecol 2004, 104:1314-1321.
8. Malak K.A., Shawki O. Management of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Gynecol Surg 2006, 3:275-280.
9. Shaw R., Symonds I.M., Tamizian O., Chaplain J., Mukhopadhyay S. Randomised comparison of thermal balloon ablation and levonorgestrel intrauterine system in patients with idiopathic menorrhagia. Aust N Z JObstet Gynaecol 2007, 47:335-340.
10. Soysal M., Soysal S., Ozer S. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralbl Gynakol 2002, 124:213-219.
11. Busfield R.A., Farquhar C.M., Sowter M.C., et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG 2006, 113:257-263.
12. Tam W.H., Yuen P.M., Shan Ng D.P., Leung P.L., Lok I.H., Rogers M.S. Health status function after treatment with thermal balloon endometrial ablation and levonorgestrel intrauterine system for idiopathic menorrhagia: a randomised study. Gynecol Obstet Invest 2006, 62:84-88.
13. Howlader N, Noone AM, Krapcho M, etal. SEER Cancer Statistics Review, 1975-2008. Bethesda, MD: National Cancer Institute. Available at , based on November 2010 SEER data submission, posted to the SEER website,2011. http://seer.cancer.gov/csr/1975_2008/.
14. Dwyer N.A., Sirrat G.M. Early endometrial carcinoma: an incidental finding after endometrial resection: case report. BJOG 1991, 98:733-734.
15. Copperman A.B., DeCherney A.H., Olive D.L. A case of endometrial cancer following endometrial ablation for dysfunctional uterine bleeding. Obstet Gynecol 1993, 82:640-642.
16. Ramey J.W., Koonings P.P., Given F.T., Acosta A.A. The process of carcinogenesis for endometrial adenocarcinoma could be short: development of a malignancy after endometrial ablation. Am J Obstet Gynecol 1994, 170:1370-1371.
17. Horowitz I.R., Copas P.R., Aaronoff M., Spann C.O., McGuire W.P. Endometrial adenocarcinoma following endometrial ablation for post menopausal bleeding. Gynecol Oncol 1995, 56:460-463.
18. Margolis M.T., Thoen L.D., Boike G.M., Mercer L.J., Keith L.G. Asymptomatic endometrial carcinoma after endometrial ablation. Int J Gynaecol Obstet 1995, 51:255-258.
19. Baggish M.S., Ringgenberg E., Sze E.H.M. Adenocarcinoma of the corpus uteri following endometrial ablation. J Gynecol Surg 1995, 11:91-94.
20. Klein Z., Markovitch O., Altaras M., Beyth Y., Fishman A. Advanced endometrial adenocarcinoma following endometrial ablation: a case report and review of the literature. Int J Gynecol Cancer 1997, 7:163-165.
21. Iqbal P.K., Paterson M.E. Endometrial carcinoma after endometrial resection for menorrhagia. Br J Obstet Gynaecol 1997, 104:1097-1098.
22. Le Marrec A., Lavoue V., Morcel K., et al. Occurrence of endometrial cancer six years after treatment with thermal balloon ablation (ThermaChoice): first case report. Eur J Obstet Gynecol Reprod Biol 2010, 150:219-220.
23. Brooks-Carter G.N., Killacky M.A., Neuwirth R.S. Adenocarcinoma of the endometrium after endometrial ablation. Obstet Gynecol 2000, 96:836-837.
24. Sandridge D.A., Councell R.B., Thorp J.M. Endometrial carcinoma arising within extensive intrauterine synechiae. Eur J Obstet Gynecol Reprod Biol 1994, 56:147-149.
25. Pillay O.C., Te Fong L.F., Crow J.C., et al. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006, 21:924-929.
26. Soliman P.T., Oh J.C., Schmeler K.M., et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005, 105:575-580.
27. Strom B.L., Schinnar R., Weber A.L., et al. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am JEpidemiol 2006, 164:775-786.
28. Beral V., Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005, 365:1543-1551. Million Women Study Collaborators.
29. Valle R.F., Baggish M.S. Endometrial carcinoma after endometrial ablation: high-risk factors predicting its occurrence. Am J Obstet Gynecol 1998, 179:569-572.
30. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 1994, 10:31-46.
31. Neuwirth R., Loffer F., Trenhaile T., Levin B. The incidence of endometrial ablation in a low-risk population. J Am Assoc Gynecol Laparosc 2004, 11:492-494.
32. Gaia G., Botchorishvili R., Canis M., et al. Endometrial cancer following endometrial resection. Gynecol Surg 2007, 4:179-185.
33. Krogh R., Lauszus F., Guttorn E., Rasmussen K. Surgery and cancer after endometrial resection: long-term follow-up on menstrual bleeding and hormone treatment by questionnaire and registry. Arch Gynecol Obstet 2009, 280:911-916.
34. Ogdie A., Langan S.M., Parkinson J., et al. Medical records databases. Pharmacoepidemiology 2012, 224-243. John Wiley & Sons, Ltd, Chichester, West Sussex, UK. 5th ed. B.L. Strom, S.E. Kimmel, S. Hennessey (Eds.).
35. Lewis J.D., Schinnar R., Bilker W.B., Wang X., Strom B.L. Validation studies of The Health Improvement Network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16:393-401.
36. Blak B.T., Thompson M. How does The Health Improvement Network (THIN) data on prevalence of chronic diseases compare with national figures?. Value Health 2009, 12:A253.
37. Haynes K., Forde K.A., Schinnar R., et al. Cancer incidence in The HealthImprovement Network. Pharmacoepidemiol Drug Saf 2009, 18:730-736.
38. Davé S., Petersen I. Creating medical and drug code lists to identify cases in primary care databases. Pharmacoepidemiol Drug Saf 2009, 18:704-707.
39. Reid P.C. Endometrial ablation in England: coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. Eur J Obstet Gynecol Reprod Biol 2007, 135:191-194.
40. Linh M.D., Wilson R.J., Ajani U.A., Singh S.D., Eheman C.R. Trends in endometrial cancer incidence rates in the United States, 1999-2006. JWomens Health (Larchmt) 2011, 20:1157-1163.
41. Schneider C., Jick S.S., Meier C.R. Risk of gynecologic cancers in users of estradiol/dihydroprogesterone of other HRT preparations. Climacteric 2009, 12:514-524.
42. deVries C.S., Bromley S.E., Thomas H., Farmer R.D. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK. Drug Saf 2005, 28:241-249.
43. Hosmer D.W., Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data 1999, Wiley-Interscience, New York, NY.
44. Marshal A., Altman D.G., Holder R.L. Comparison of imputation methods for handling missing covariate data when fitting a Cox proportion hazards model: a resampling study. BMC Res Methodol 2010, 10:112.
45. Lin D.Y., Psaty B.M., Kronmal R.A. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998, 54:948-963.
46. Cooper K., Lee A., Chien P., Raja E., Timmaraju V., Bhattacharya S. Outcomesfollowing hysterectomy or endometrial ablation for heavy menstrual bleeding: retrospective analysis of hospital episode statistics in Scotland. BJOG 2011, 118:1171-1179.
47. Office for National Statistics, Cancer Statistics Registrations. Registrations of cancer diagnosed in 2008, England. Series MB1 No.39. London, UK: National Statistics;2010.
48. Flegal K., Carroll M., Kit B., Ogden C. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012, 307:491-497.
49. Endometrial Ablation Advisory Group, Endometrial Ablation Service. NHS Commissioning Guide. December 2007:8.